By Matt Lynn
Print Length 297 pages
Publisher Endeavour Media; 1 edition (5th Dec 2013)
Publisher Endeavour Media; 1 edition (5th Dec 2013)
ASIN B00BCN1H9M
This book was a bit too 'talky' and not enough action for me. Fine if you like that sort of thing but I found the pharmaceutical / stocks & shares chatter a bit too much at times. I only managed to finish because it didn't exceed 300 pages.
Barnsey's Books Rating ⭐⭐
📗The Blurb
Jack Borrodin has a new job.
Jack Borrodin has a new job.
He thinks he is just one step away from a seat on the board of one of the world's largest pharmaceutical companies.
Tara Ling has a new job.
An expert in leprosy, she has been hired by Jack's company to work on creating a vaccine against a deadly new virus.
Outwardly a respectable conglomerate, the closer to its core Jack and Tara get, the more rotten it appears. Framed for crimes they did not commit, Jack and Tara have two weeks strike back at the company that deceived them.
Unless the company strikes them down first.
No comments:
Post a Comment